Diagnosis and Management of Systematic Lupus Erythematosus (SLE) | ||
| The Egyptian Journal of Hospital Medicine | ||
| Article 20, Volume 67, Issue 2, April 2017, Pages 672-678 PDF (335.58 K) | ||
| Document Type: Original Article | ||
| DOI: 10.12816/0037820 | ||
| Authors | ||
| Yousef Taleb Gaafar AL-katheri1; Foad Assad M Bukhari2; Murad Muneer Mawlawi3; AL NIHAB ALI NAJI A4; Reem Ahmed B Alanazi5; Bayan Saeed A Alghamdi1; Ahdab Abdulmuti Alkubaydi6; Nada Talal Ibrahem Bima6; Rayan Marzooq F Almutairi7; Abdullah Salem Z Alghamdi7 | ||
| 1Ibn Sina College | ||
| 2King Abdulaziz University | ||
| 3King Fahd General Hospital | ||
| 4Anak General Hospital | ||
| 5Almaarefa collage | ||
| 6ibn Sina College | ||
| 7Umm Alqura University | ||
| Abstract | ||
| Background: Systemic lupus erythematosus (SLE) is the prototypic multisystem autoimmune disorder with a wide range of clinical presentations impacting almost all organs and tissues, such extreme heterogeneity suggests that SLE represents a syndrome rather than a single disease. Although the precise etiologic mechanism is unknown, genetic, hormonal, and environmental factors, as well as immune abnormalities, have been detected. Associations between lupus onset and age, sex, geography, and race have also been established. Aim of the work: This review will focus on advances in the diagnosis and management of SLE. Conclusion: The diagnosis of SLE must be based on the proper constellation of clinical findings and laboratory evidence. Management of this disease should be individualized and should include both pharmacological and non-pharmacological modalities for symptom relief and resolution as well as improved quality of life. | ||
| Keywords | ||
| Systematic Lupus Erythematosus; connective tissue disorder SLE; NSAID | ||
|
Statistics Article View: 464 PDF Download: 1,208 |
||
